Clinical Trials Directory

Trials / Completed

CompletedNCT05019768

Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS

Topo-pachimetric Accelerated Epi-On Cross-linking Compared to Dresden Protocol Using Riboflavin With Vitamin E TPGS: Results of a 2-year Randomized Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Ciro Caruso · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the present study the investigators compare the clinical outcome corneal cross linking with either the stand-ard Dresden (sCXL) or the accelerated custom-fast (aCFXL) ultraviolet A irradiation protocol using riboflavin-D-α-Tocopheryl polyethyleneglycol1000 succinate for progressive keratoconus.

Conditions

Interventions

TypeNameDescription
OTHERaccelerated custom-fast CXLThe accelerated custom fast CXL (aCFXL) has been developed on a published mathematical model that takes into consideration objective variables such as the equation governing the UVA-induced riboflavin consumption rate and the corneal thickness at its thinnest point. By knowing both values, the mathematical model allows to objectively calculate both the exact UVA irradiation value (intensity), expressed in mW/cm2, and the irradiation time
OTHERStandard CXLThe standard CXL procedure has been carried on following the Dresden protocol

Timeline

Start date
2017-09-01
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2021-08-25
Last updated
2021-08-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05019768. Inclusion in this directory is not an endorsement.